Chemoinformaics analysis of Spirost-25(27)-ene-1,3-diol, (1beta,3alpha,5alpha)-
| Molecular Weight | 430.629 | nRot | 0 |
| Heavy Atom Molecular Weight | 388.293 | nRig | 31 |
| Exact Molecular Weight | 430.308 | nRing | 6 |
| Solubility: LogS | -4.531 | nHRing | 2 |
| Solubility: LogP | 4.428 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 76.3033 |
| nHD | 2 | BPOL | 45.6067 |
| QED | 0.548 |
| Synth | 5.578 |
| Natural Product Likeliness | 3.606 |
| NR-PPAR-gamma | 0.067 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.104 |
| Pgp-sub | 0.941 |
| HIA | 0.004 |
| CACO-2 | -4.774 |
| MDCK | 0.0000102 |
| BBB | 0.816 |
| PPB | 0.503962 |
| VDSS | 1.656 |
| FU | 0.402256 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.75 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.8 |
| CYP2c9-inh | 0.073 |
| CYP2c9-sub | 0.022 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.323 |
| CYP3a4-inh | 0.368 |
| CYP3a4-sub | 0.286 |
| CL | 12.8 |
| T12 | 0.216 |
| hERG | 0.93 |
| Ames | 0.079 |
| ROA | 0.814 |
| SkinSen | 0.949 |
| Carcinogencity | 0.806 |
| EI | 0.08 |
| Respiratory | 0.95 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.742084 |